{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:16Z","timestamp":1787003836293,"version":"build-2736575974"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite Egypt\u2019s landmark achievement in controlling hepatitis C virus (HCV) and receiving WHO validation on the path to elimination, long-term sequelae among men previously affected by chronic HCV remain under-recognized. Sexual dysfunction is an important yet often overlooked component of survivorship and quality of life in chronic liver disease care. To estimate the prevalence and identify factors independently associated with sexual dysfunction among Egyptian men with chronic HCV, informing post-elimination care strategies. A cross-sectional analysis was conducted on 1,500 adult males attending National Committee for Control of Viral Hepatitis (NCCVH) units across six geographically diverse Egyptian governorates. Sexual health was assessed using the Brief Sexual Symptom Checklist for Men and the International Index of Erectile Function (IIEF-5). Logistic regression was applied to identify factors independently associated with sexual dysfunction. The overall prevalence of at least one form of sexual dysfunction was 72.8%. Erectile dysfunction was most common (59.3%), followed by desire dysfunction (47.5%) and premature ejaculation (32.1%), orgasmic dysfunction (27.8%), and dyspareunia (12.6%). The strongest independent associations clustered around markers of advanced disease severity and complications, particularly hepatocellular carcinoma (DD AOR: 12.39; 95% CI: 4.64\u201333.09; PE AOR: 8.99; 95% CI: 2.06\u201339.25) and age\u2009\u2265\u200950 years (DD AOR: 5.00; 95% CI: 3.65\u20136.85; PE AOR: 7.58; 95% CI: 4.17\u201313.76). Diabetes mellitus was also strongly associated with erectile dysfunction (AOR: 3.89; 95% CI: 2.07\u20137.30) and premature ejaculation (AOR: 3.33; 95% CI: 1.72\u20136.44). Sexual dysfunction is a common, under-recognized sequela among Egyptian men with chronic HCV in the post-elimination era. The strongest independent associations were observed with advanced liver disease\/complications and metabolic comorbidity, supporting integration of routine sexual health assessment and counseling into post-HCV follow-up. Survivorship-oriented care is particularly important for patients with advanced liver disease.<\/jats:p>","DOI":"10.1038\/s41598-026-37013-z","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:03:55Z","timestamp":1771506235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sexual dysfunction among Egyptian men with chronic hepatitis C in the post elimination era prevalence and associated factors"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-5202","authenticated-orcid":false,"given":"Ammal M.","family":"Metwally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahi M","family":"Al-Tehewy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihad A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa A.","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan S.","family":"Ezelarab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runia F.","family":"El-Folly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem M.","family":"El-Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"1","key":"37013_CR1","first-page":"153","volume":"66","author":"EASL (European Association for the Study of the Liver)","year":"2016","unstructured":"EASL (European Association for the Study of the Liver). Recommendations on treatment of hepatitis C. J. Hepatol. 66 (1), 153\u2013194 (2016).","journal-title":"J. Hepatol."},{"issue":"1","key":"37013_CR2","doi-asserted-by":"publisher","first-page":"89469","DOI":"10.5501\/wjv.v13.i1.89469","volume":"13","author":"H Ali","year":"2024","unstructured":"Ali, H. et al. Global trends in hepatitis C-related hepatocellular carcinoma mortality: a public database analysis (1999\u20132019). World J. Virol. 13 (1), 89469. https:\/\/doi.org\/10.5501\/wjv.v13.i1.89469 (2024). PMID: 38616850; PMCID: PMC11008397.","journal-title":"World J. Virol."},{"key":"37013_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/liv.13186","volume":"37","author":"A Kandeel","year":"2017","unstructured":"Kandeel, A. et al. The prevalence of HCV infection in Egypt 2015: implications for future policy on prevention and treatment. Liver Int. 37, 45\u201353 (2017).","journal-title":"Liver Int."},{"key":"37013_CR4","unstructured":"World Health Organization. Egypt becomes the first country to achieve WHO validation on the path to elimination of hepatitis C [Internet]. Cairo: WHO Regional Office for the Eastern Mediterranean. (2023). Available from: https:\/\/www.emro.who.int\/media\/news\/egypt-becomes-the-first-country-to-achieve-who-validation-on-the-path-to-elimination-of-hepatitis-c.html"},{"issue":"12","key":"37013_CR5","first-page":"806","volume":"7","author":"A Metwally","year":"2013","unstructured":"Metwally, A. et al. Impact of hepatitis C virus chronic infection on quality of life in Egypt. Int. J. Med. Sci. Eng. 7 (12), 806\u2013813 (2013).","journal-title":"Int. J. Med. Sci. Eng."},{"issue":"1","key":"37013_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1477-7525-12-97","volume":"12","author":"SC Chang","year":"2014","unstructured":"Chang, S. C. et al. Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQ. Health Qual. Life Outcomes. 12 (1), 97 (2014).","journal-title":"Health Qual. Life Outcomes"},{"issue":"12","key":"37013_CR7","first-page":"819","volume":"7","author":"A Metwally","year":"2013","unstructured":"Metwally, A. et al. Assessing psycho-social stressors for chronically infected hepatitis C virus patients in Egypt. Int. J. Med. Sci. Eng. 7 (12), 819\u2013828 (2013).","journal-title":"Int. J. Med. Sci. Eng."},{"issue":"2","key":"37013_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/ijir.2016.5","volume":"28","author":"J Vergniol","year":"2016","unstructured":"Vergniol, J. et al. Sexual quality of life is impaired in patients with chronic hepatitis C. Int. J. Impot. Res. 28 (2), 68 (2016).","journal-title":"Int. J. Impot. Res."},{"issue":"11","key":"37013_CR9","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1111\/j.1743-6109.2010.02062.x","volume":"7","author":"F Montorsi","year":"2010","unstructured":"Montorsi, F. et al. Summary of the recommendations on sexual dysfunctions in men. J. Sex. Med. 7 (11), 3572\u20133588 (2010).","journal-title":"J. Sex. Med."},{"issue":"1","key":"37013_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ajg.2014.01.012","volume":"15","author":"SS Hunter","year":"2014","unstructured":"Hunter, S. S., Gadallah, A., Azawi, M. K. & Doss, W. Erectile dysfunction in patients with chronic hepatitis C virus infection. Arab. J. Gastroenterol. 15 (1), 16\u201320 (2014).","journal-title":"Arab. J. Gastroenterol."},{"issue":"18","key":"37013_CR11","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.3748\/wjg.v21.i18.5641","volume":"21","author":"BO Ma","year":"2015","unstructured":"Ma, B. O., Shim, S. G. & Yang, H. J. Association of erectile dysfunction with depression in patients with chronic viral hepatitis. World J. Gastroenterol. 21 (18), 5641 (2015).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"37013_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajg.2017.02.002","volume":"18","author":"AFA Hasanain","year":"2017","unstructured":"Hasanain, A. F. A. et al. Erectile dysfunction in patients with nonalcoholic fatty liver disease. Arab. J. Gastroenterol. 18 (1), 21\u201324 (2017).","journal-title":"Arab. J. Gastroenterol."},{"issue":"5","key":"37013_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jhep.2016.06.007","volume":"65","author":"M Sinclair","year":"2016","unstructured":"Sinclair, M., Grossmann, M., Hoermann, R., Angus, P. W. & Gow, P. J. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial. J. Hepatol. 65 (5), 906\u2013913 (2016).","journal-title":"J. Hepatol."},{"key":"37013_CR14","doi-asserted-by":"publisher","first-page":"16003","DOI":"10.1038\/nrdp.2016.3","volume":"2","author":"FA Yafi","year":"2016","unstructured":"Yafi, F. A. et al. Erectile dysfunction. Nat. Rev. Dis. Primers. 2, 16003 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"37013_CR15","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.4254\/wjh.v14.i8.1530","volume":"14","author":"RK Jagdish","year":"2022","unstructured":"Jagdish, R. K. Sexual dysfunctions and their treatment in liver diseases. World J. Hepatol. 14 (8), 1530\u20131540. https:\/\/doi.org\/10.4254\/wjh.v14.i8.1530 (2022). PMID: 36157870; PMCID: PMC9453461.","journal-title":"World J. Hepatol."},{"issue":"5","key":"37013_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.21608\/zumj.2019.13982.1278","volume":"26","author":"A Nosair","year":"2020","unstructured":"Nosair, A., Ismail, W., Hamed, E. & Salem, G. Health-related quality of life in Egyptian patients with chronic hepatitis C before and after treatment with direct-acting antivirals. Zagazig Univ. Med. J. 26 (5), 877\u2013882. https:\/\/doi.org\/10.21608\/zumj.2019.13982.1278 (2020).","journal-title":"Zagazig Univ. Med. J."},{"key":"37013_CR17","unstructured":"Salem, M., Abdel Aziz Rady, H. E., Wadie, N. A. & Seif-Eldein, S. Stigma and quality of life as perceived by patients with hepatitis C virus. Int J Novel Res Healthc Nurs. 7(1):900\u2013909. (2020). Available from: http:\/\/www.noveltyjournals.com"},{"key":"37013_CR18","unstructured":"World Health Organization. Egypt becomes the first country to achieve WHO validation on the path to elimination of hepatitis C & WHO Regional Office for the Eastern Mediterranean. Jun 19. (2023). Available from: https:\/\/www.emro.who.int\/media\/news\/egypt-becomes-the-first-country-to-achieve-who-validation-on-the-path-to-elimination-of-hepatitis-c.html"},{"issue":"1","key":"37013_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/2090598X.2023.2238933","volume":"22","author":"M Fakhry","year":"2023","unstructured":"Fakhry, M. et al. Prevalence and risk factors of erectile dysfunction in cirrhotic patients: an observational study. Arab. J. Urol. 22 (1), 6\u201312 (2023). PMID: 38205383; PMCID: PMC10776039.","journal-title":"Arab. J. Urol."},{"issue":"4","key":"37013_CR20","doi-asserted-by":"publisher","first-page":"e0691","DOI":"10.1097\/HC9.0000000000000691","volume":"9","author":"A Ferrarese","year":"2025","unstructured":"Ferrarese, A., Hurtado D\u00edaz de Le\u00f3n, I., Tapper, E. B. & Burra, P. Sexual health and function in liver disease. Hepatol. Commun. 9 (4), e0691. https:\/\/doi.org\/10.1097\/HC9.0000000000000691 (2025).","journal-title":"Hepatol. Commun."},{"key":"37013_CR21","doi-asserted-by":"publisher","unstructured":"Yoo, H. J. et al. Prevalence and risk factors of erectile dysfunction in patients with liver cirrhosis: a systematic review and meta-analysis. Hepatol Int. 17(2):452\u201362. (2023). https:\/\/doi.org\/10.1007\/s12072-021-10270-y. PMID: 34799837.","DOI":"10.1007\/s12072-021-10270-y"},{"issue":"1","key":"37013_CR22","doi-asserted-by":"publisher","first-page":"e0190","DOI":"10.1097\/CLD.0000000000000190","volume":"23","author":"M Maxwell","year":"2024","unstructured":"Maxwell, M., Alvarado, M. & Khungar, V. Approach to sexual dysfunction in patients with chronic liver disease. Clin. Liver Dis. (Hoboken). 23 (1), e0190. https:\/\/doi.org\/10.1097\/CLD.0000000000000190 (2024).","journal-title":"Clin. Liver Dis. (Hoboken)"},{"issue":"6","key":"37013_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cgh.2017.12.028","volume":"16","author":"ZM Younossi","year":"2018","unstructured":"Younossi, Z. M. Patient-reported outcomes for patients with chronic liver disease. Clin. Gastroenterol. Hepatol. 16 (6), 793\u2013799. https:\/\/doi.org\/10.1016\/j.cgh.2017.12.028 (2018). Epub 2018 Apr 19. PMID: 29680284.","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"37013_CR24","unstructured":"World Health Organization, Hepatitis, C. & Fact Sheet (2023). Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"issue":"1","key":"37013_CR25","first-page":"489","volume":"9","author":"AM Metwally","year":"2013","unstructured":"Metwally, A. M. et al. Hepatitis C and depression: do hepatitis C virus chronic patients need psychological support? J. Appl. Sci. Res. 9 (1), 489\u2013497 (2013).","journal-title":"J. Appl. Sci. Res."},{"issue":"2","key":"37013_CR26","doi-asserted-by":"publisher","first-page":"e0242257","DOI":"10.1371\/journal.pone.0242257","volume":"16","author":"AM Metwally","year":"2021","unstructured":"Metwally, A. M. et al. Accelerating hepatitis C virus elimination in Egypt by 2030: A National survey of communication for behavioral development as a modelling study. PLoS One. 16 (2), e0242257. https:\/\/doi.org\/10.1371\/journal.pone.0242257 (2021). PMID: 33621232; PMCID: PMC7901784.","journal-title":"PLoS One"},{"issue":"6","key":"37013_CR27","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1572-0241.2006.00544.x","volume":"101","author":"A Danoff","year":"2006","unstructured":"Danoff, A. et al. Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life. Am. J. Gastroenterol. 101 (6), 1235 (2006).","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"37013_CR28","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jhep.2014.06.034","volume":"61","author":"JG Orr","year":"2014","unstructured":"Orr, J. G. et al. Health-related quality of life in people with advanced chronic liver disease. J. Hepatol. 61 (5), 1158\u20131165 (2014).","journal-title":"J. Hepatol."},{"issue":"11\u201312","key":"37013_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1365-2036.2005.02691.x","volume":"22","author":"E Cholongitas","year":"2005","unstructured":"Cholongitas, E. et al. Systematic review: the model for end-stage liver disease\u2014should it replace Child-Pugh\u2019s classification for assessing prognosis in cirrhosis? Aliment. Pharmacol. Ther. 22 (11\u201312), 1079\u20131089 (2005).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"37013_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"RC Rosen","year":"1999","unstructured":"Rosen, R. C., Cappelleri, J. C., Smith, M. D., Lipsky, J. & Pena, B. M. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int. J. Impot. Res. 11 (6), 319 (1999).","journal-title":"Int. J. Impot. Res."},{"issue":"1","key":"37013_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1743-6109.2004.10108.x","volume":"1","author":"D Hatzichristou","year":"2004","unstructured":"Hatzichristou, D. et al. Clinical evaluation and management strategy for sexual dysfunction in men and women. J. Sex. Med. 1 (1), 49\u201357 (2004).","journal-title":"J. Sex. Med."},{"key":"37013_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.ijir.3900859","volume":"14","author":"EL Rhoden","year":"2002","unstructured":"Rhoden, E. L., Tel\u00f6ken, C., Sogari, P. R. & Vargas Souto, C. A. The use of the simplified international index of erectile function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int. J. Impot. Res. 14, 245\u2013250. https:\/\/doi.org\/10.1038\/sj.ijir.3900859 (2002).","journal-title":"Int. J. Impot. Res."},{"key":"37013_CR33","unstructured":"IBM Corp. IBM SPSS Statistics for Windows, Version 24.0 (IBM Corp, 2016)."},{"issue":"1","key":"37013_CR34","first-page":"10","volume":"7","author":"NN Naing","year":"2000","unstructured":"Naing, N. N. Easy way to learn standardization: direct and indirect methods. Malays J. Med. Sci. 7 (1), 10 (2000).","journal-title":"Malays J. Med. Sci."},{"issue":"1","key":"37013_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/sjg.sjg_357_21","volume":"28","author":"Y Fouad","year":"2022","unstructured":"Fouad, Y. et al. The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Saudi J. Gastroenterol. 28 (1), 3\u201320. https:\/\/doi.org\/10.4103\/sjg.sjg_357_21 (2022). PMID: 35083973; PMCID: PMC8919931.","journal-title":"Saudi J. Gastroenterol."},{"key":"37013_CR36","doi-asserted-by":"publisher","unstructured":"Youssef, N. F., Shepherd, A. & Evans, J. M. Factors associated with health-related quality of life among patients with liver cirrhosis in Egypt. J Egypt Public Health Assoc. ; 90 (1):14\u2009\u2013\u20099. (2015). https:\/\/doi.org\/10.1097\/01.EPX.0000461923.98204.f5. PMID: 25853540.","DOI":"10.1097\/01.EPX.0000461923.98204.f5"},{"issue":"1","key":"37013_CR37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12889-025-21668-w","volume":"25","author":"JM Gizamba","year":"2025","unstructured":"Gizamba, J. M., Finch, B. K., Wang, S. & Klausner, J. D. Insights into the Spatial epidemiology of hepatitis C infection: systematic synthesis of area-level determinants and Spatiotemporal analyses. BMC Public. Health. 25 (1), 687. https:\/\/doi.org\/10.1186\/s12889-025-21668-w (2025). PMID: 39972312; PMCID: PMC11841175.","journal-title":"BMC Public. Health"},{"issue":"7\u20138","key":"37013_CR38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.14745\/ccdr.v44i78a03","volume":"44","author":"N Shehata","year":"2018","unstructured":"Shehata, N., Austin, T., Ha, S. & Timmerman, K. Barriers to and facilitators of hepatitis C virus screening and testing: a scoping review. Can. Commun. Dis. Rep. 44 (7\u20138), 166\u2013172. https:\/\/doi.org\/10.14745\/ccdr.v44i78a03 (2018). PMID: 31011297; PMCID: PMC6449117.","journal-title":"Can. Commun. Dis. Rep."},{"issue":"5","key":"37013_CR39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/10105395241254870","volume":"36","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Epidemiological features of hepatitis C in China from 2015 to 2021: insights from National surveillance data. Asia Pac. J. Public. Health. 36 (5), 447\u2013454. https:\/\/doi.org\/10.1177\/10105395241254870 (2024).","journal-title":"Asia Pac. J. Public. Health"},{"key":"37013_CR40","doi-asserted-by":"publisher","unstructured":"Alter, M. J. et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 341(8):556\u201362. (1999). https:\/\/doi.org\/10.1056\/NEJM199908193410802. PMID: 10451460.","DOI":"10.1056\/NEJM199908193410802"},{"issue":"1","key":"37013_CR41","doi-asserted-by":"publisher","first-page":"100932","DOI":"10.1016\/j.jhepr.2023.100932","volume":"6","author":"J Llaneras","year":"2023","unstructured":"Llaneras, J. et al. Integrating viral hepatitis management into the emergency department: a further step towards viral hepatitis elimination. JHEP Rep. 6 (1), 100932. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100932 (2023). PMID: 38074506; PMCID: PMC10698271.","journal-title":"JHEP Rep."},{"issue":"4","key":"37013_CR42","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/medicina61040614","volume":"61","author":"EG Giannini","year":"2025","unstructured":"Giannini, E. G. et al. A real-world analysis of the population with hepatitis C virus infection affected by type 2 diabetes in italy: patients\u2019 characteristics, comorbidity profiles, and treatment patterns. Med. (Kaunas). 61 (4), 614. https:\/\/doi.org\/10.3390\/medicina61040614 (2025). PMID: 40282905; PMCID: PMC12028345.","journal-title":"Med. (Kaunas)"},{"issue":"8","key":"37013_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/pathogens13080681","volume":"13","author":"A Gomaa","year":"2024","unstructured":"Gomaa, A., Gomaa, M., Allam, N. & Waked, I. Hepatitis C elimination in egypt: story of success. Pathogens 13 (8), 681. https:\/\/doi.org\/10.3390\/pathogens13080681 (2024). PMID: 39204281; PMCID: PMC11357586.","journal-title":"Pathogens"},{"issue":"4","key":"37013_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3350\/cmh.2015.21.4.352","volume":"21","author":"M Kim","year":"2015","unstructured":"Kim, M., Kim, S. Y., Rou, W. S., Hwang, S. W. & Lee, B. S. Erectile dysfunction in patients with liver disease related to chronic hepatitis B. Clin. Mol. Hepatol. 21 (4), 352 (2015).","journal-title":"Clin. Mol. Hepatol."},{"issue":"2","key":"37013_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.dld.2014.10.018","volume":"47","author":"W Kreisel","year":"2015","unstructured":"Kreisel, W. et al. The phosphodiesterase-5 inhibitor Udenafil lowers portal pressure in compensated preascitic liver cirrhosis: a dose-finding phase II study. Dig. Liver Dis. 47 (2), 144\u2013150 (2015).","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"37013_CR46","doi-asserted-by":"publisher","first-page":"e0280915","DOI":"10.1371\/journal.pone.0280915","volume":"18","author":"D Darmadi","year":"2023","unstructured":"Darmadi, D., Pakpahan, C., Ruslie, R. H., Amanda, B. & Ibrahim, R. The sex life of male patients with cirrhosis and its organic factors: what we have got so far? PLoS One. 18 (2), e0280915. https:\/\/doi.org\/10.1371\/journal.pone.0280915 (2023). PMID: 36730272; PMCID: PMC9894452.","journal-title":"PLoS One"},{"key":"37013_CR47","doi-asserted-by":"publisher","first-page":"1092353","DOI":"10.3389\/fpubh.2022.1092353","volume":"10","author":"G Zang","year":"2023","unstructured":"Zang, G. et al. Chronic liver diseases and erectile dysfunction. Front. Public. Health. 10, 1092353. https:\/\/doi.org\/10.3389\/fpubh.2022.1092353 (2023). PMID: 36684968; PMCID: PMC9853559.","journal-title":"Front. Public. Health"},{"key":"37013_CR48","doi-asserted-by":"publisher","unstructured":"Younossi, Z. M. et al. Assessment of fatigue and its impact in chronic liver disease. J Hepatol. 81(4):726\u201342. (2024). https:\/\/doi.org\/10.1016\/j.jhep.2024.04.008. PMID: 38670320.","DOI":"10.1016\/j.jhep.2024.04.008"},{"issue":"2","key":"37013_CR49","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jceh.2021.08.028","volume":"12","author":"K Bhandari","year":"2022","unstructured":"Bhandari, K. & Kapoor, D. Fatigue in cirrhosis. J. Clin. Exp. Hepatol. 12 (2), 617\u2013624 (2022).","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"3","key":"37013_CR50","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11154-018-9455-1","volume":"19","author":"S Fabiani","year":"2018","unstructured":"Fabiani, S., Fallahi, P., Ferrari, S. M., Miccoli, M. & Antonelli, A. Hepatitis C virus infection and development of type 2 diabetes mellitus: systematic review and meta-analysis of the literature. Rev. Endocr. Metab. Disord. 19 (3), 289\u2013300. https:\/\/doi.org\/10.1007\/s11154-018-9455-1 (2018).","journal-title":"Rev. Endocr. Metab. Disord"},{"issue":"2","key":"37013_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/1596-3519.134403","volume":"13","author":"O Adekanle","year":"2014","unstructured":"Adekanle, O., Ndububa, D. A., Orji, E. O. & Ijarotimi, O. Assessment of the sexual functions of males with chronic liver disease in South West Nigeria. Ann. Afr. Med. 13 (2), 81\u201385. https:\/\/doi.org\/10.4103\/1596-3519.134403 (2014).","journal-title":"Ann. Afr. Med."},{"key":"37013_CR52","doi-asserted-by":"publisher","unstructured":"Berkman, N. D., Sheridan, S. L., Donahue, K. E., Halpern, D. J. & Crotty, K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 155(2):97\u2013107. (2011). https:\/\/doi.org\/10.7326\/0003-4819-155-2-201107190-00005. PMID: 21768583.","DOI":"10.7326\/0003-4819-155-2-201107190-00005"},{"key":"37013_CR53","doi-asserted-by":"publisher","unstructured":"Nutbeam, D. The evolving concept of health literacy. Soc Sci Med. 67(12):2072\u20138. (2008). https:\/\/doi.org\/10.1016\/j.socscimed.2008.09.050. PMID: 18952344.","DOI":"10.1016\/j.socscimed.2008.09.050"},{"issue":"3","key":"37013_CR54","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/17538068.2023.2192579","volume":"16","author":"AS Ram\u00edrez","year":"2023","unstructured":"Ram\u00edrez, A. S. et al. Communicating about the social determinants of health: development of a local brand. J. Commun. Healthc. 16 (3), 231\u2013238 (2023). PMID: 36946864; PMCID: PMC10514231.","journal-title":"J. Commun. Healthc."},{"issue":"1","key":"37013_CR55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12902-021-00807-5","volume":"21","author":"M Zeleke","year":"2021","unstructured":"Zeleke, M., Hailu, D. & Daka, D. Erectile dysfunction and associated factors among diabetic patients at Hawassa, Southern Ethiopia. BMC Endocr. Disord. 21 (1), 139. https:\/\/doi.org\/10.1186\/s12902-021-00807-5 (2021). PMID: 34210295; PMCID: PMC8252293.","journal-title":"BMC Endocr. Disord"},{"issue":"4","key":"37013_CR56","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/apt.14493","volume":"47","author":"ZM Younossi","year":"2018","unstructured":"Younossi, Z. M. Direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection \u2013 Author\u2019s reply. Aliment. Pharmacol. Ther. 47 (4), 537\u2013538. https:\/\/doi.org\/10.1111\/apt.14493 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"37013_CR57","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/jcm12062195","volume":"12","author":"EN Lynch","year":"2023","unstructured":"Lynch, E. N. et al. Outcomes and Follow-Up after hepatitis C eradication with Direct-Acting antivirals. J. Clin. Med. 12 (6), 2195 (2023).","journal-title":"J. Clin. Med."},{"key":"37013_CR58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2490-15-6","volume":"15","author":"M Martyn-St James","year":"2015","unstructured":"Martyn-St James, M. et al. Tramadol for premature ejaculation: a systematic review and meta-analysis. BMC Urol. 15, 6. https:\/\/doi.org\/10.1186\/1471-2490-15-6 (2015).","journal-title":"BMC Urol."},{"issue":"2","key":"37013_CR59","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4103\/0974-7796.150481","volume":"7","author":"A Kurkar","year":"2015","unstructured":"Kurkar, A. et al. A randomized, double-blind, placebo-controlled, crossover trial of on-demand Tramadol for treatment of premature ejaculation. Urol. Ann. 7 (2), 205\u2013210. https:\/\/doi.org\/10.4103\/0974-7796.150481 (2015). PubMed.","journal-title":"Urol. Ann."},{"issue":"4","key":"37013_CR60","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.eururo.2011.08.039","volume":"61","author":"D Bar-Or","year":"2012","unstructured":"Bar-Or, D. et al. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the Tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. Eur. Urol. 61 (4), 736\u2013743. https:\/\/doi.org\/10.1016\/j.eururo.2011.08.039 (2012). PubMed.","journal-title":"Eur. Urol."},{"issue":"1","key":"37013_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.jcp.0000195064.89573.d2","volume":"26","author":"MR Safarinejad","year":"2006","unstructured":"Safarinejad, M. R. & Hosseini, S. Y. Safety and efficacy of Tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J. Clin. Psychopharmacol. 26 (1), 27\u201331. https:\/\/doi.org\/10.1097\/01.jcp.0000195064.89573.d2 (2006).","journal-title":"J. Clin. Psychopharmacol."},{"key":"37013_CR62","doi-asserted-by":"publisher","unstructured":"Bassiony, M. M. et al. Opioid use disorders attributed to tramadol among Egyptian university students. J Addict Med. 12(2):150\u20135. (2018). https:\/\/doi.org\/10.1097\/ADM.0000000000000380. PMID: 29334513.","DOI":"10.1097\/ADM.0000000000000380"},{"issue":"4","key":"37013_CR63","doi-asserted-by":"publisher","first-page":"00060","DOI":"10.15406\/frcij.2016.02.00060","volume":"2","author":"HS Youssef","year":"2016","unstructured":"Youssef, H. S. & Azza, Z. H. M. Histo-pathological and biochemical effects of acute and chronic Tramadol drug toxicity on liver, kidney and testicular function in adult male albino rats. Forensic Res. Criminol. Int. J. 2 (4), 00060. https:\/\/doi.org\/10.15406\/frcij.2016.02.00060 (2016).","journal-title":"Forensic Res. Criminol. Int. J."},{"issue":"4","key":"37013_CR64","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2478\/intox-2019-0019","volume":"12","author":"A Kabbash","year":"2019","unstructured":"Kabbash, A., El Kelany, R., Oreby, M. & El Gameel, A. Effect of Tramadol dependence on male sexual dysfunction. Interdiscip Toxicol. 12 (4), 157\u2013162. https:\/\/doi.org\/10.2478\/intox-2019-0019 (2019). PubMed.","journal-title":"Interdiscip Toxicol."},{"issue":"3","key":"37013_CR65","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.sxmr.2015.10.014","volume":"4","author":"IA Abdel-Hamid","year":"2016","unstructured":"Abdel-Hamid, I. A., Andersson, K-E., Waldinger, M. D. & Anis, T. H. Tramadol abuse and sexual function. Sex. Med. Rev. 4 (3), 235\u2013246. https:\/\/doi.org\/10.1016\/j.sxmr.2015.10.014 (2016). PubMed.","journal-title":"Sex. Med. Rev."},{"issue":"10","key":"37013_CR66","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jsxm.2017.08.010","volume":"14","author":"S Zhao","year":"2017","unstructured":"Zhao, S. et al. Association between opioid use and risk of erectile dysfunction: a systematic review and meta-analysis. J. Sex. Med. 14 (10), 1209\u20131219. https:\/\/doi.org\/10.1016\/j.jsxm.2017.08.010 (2017).","journal-title":"J. Sex. Med."},{"key":"37013_CR67","doi-asserted-by":"publisher","unstructured":"Reddy, R. G., Aung, T., Karavitaki, N. & Wass, J. A. H. Opioid-induced hypogonadism. BMJ. 340:c446. (2010). https:\/\/doi.org\/10.1136\/bmj.c446. PMC.","DOI":"10.1136\/bmj.c446"},{"key":"37013_CR68","doi-asserted-by":"publisher","first-page":"1084455","DOI":"10.3389\/fnut.2022.1084455","volume":"9","author":"M Zamani","year":"2023","unstructured":"Zamani, M. et al. The effects of green tea supplementation on cardiovascular risk factors: a systematic review and meta-analysis. Front. Nutr. 9, 1084455. https:\/\/doi.org\/10.3389\/fnut.2022.1084455 (2023). PMID: 36704803; PMCID: PMC9871939.","journal-title":"Front. Nutr."},{"issue":"2","key":"37013_CR69","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.phrs.2011.03.009","volume":"64","author":"A Deka","year":"2011","unstructured":"Deka, A. & Vita, J. A. Tea and cardiovascular disease. Pharmacol. Res. 64 (2), 136\u2013145. https:\/\/doi.org\/10.1016\/j.phrs.2011.03.009 (2011). PMID: 21477653; PMCID: PMC3123419.","journal-title":"Pharmacol. Res."},{"key":"37013_CR70","doi-asserted-by":"publisher","unstructured":"Lorenz, M. et al. Tea-induced improvement of endothelial function in humans: no role for epigallocatechin gallate (EGCG). Sci Rep. 7(1):2279. (2017). https:\/\/doi.org\/10.1038\/s41598-017-02384-x. PubMed.","DOI":"10.1038\/s41598-017-02384-x"},{"issue":"23","key":"37013_CR71","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2169\/internalmedicine.49.4048","volume":"49","author":"J-I Oyama","year":"2010","unstructured":"Oyama, J-I. et al. Green tea catechins improve human forearm vascular function and have potent anti-inflammatory and anti-apoptotic effects in smokers. Intern. Med. 49 (23), 2553\u20132559. https:\/\/doi.org\/10.2169\/internalmedicine.49.4048 (2010). PubMed.","journal-title":"Intern. Med."},{"issue":"4","key":"37013_CR72","doi-asserted-by":"publisher","first-page":"e0123547","DOI":"10.1371\/journal.pone.0123547","volume":"10","author":"DS Lopez","year":"2015","unstructured":"Lopez, D. S. et al. Role of caffeine intake on erectile dysfunction in US men: results from NHANES 2001\u20132004. PLoS One. 10 (4), e0123547. https:\/\/doi.org\/10.1371\/journal.pone.0123547 (2015).","journal-title":"PLoS One"},{"key":"37013_CR73","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s41043-024-00645-w","volume":"43","author":"M Karimi","year":"2024","unstructured":"Karimi, M. et al. Association between caffeine intake and erectile dysfunction: a meta-analysis of cohort studies. J. Health Popul. Nutr. 43, 154. https:\/\/doi.org\/10.1186\/s41043-024-00645-w (2024).","journal-title":"J. Health Popul. Nutr."},{"issue":"10","key":"37013_CR74","first-page":"1385","volume":"43","author":"A Metwally","year":"2014","unstructured":"Metwally, A. et al. Prioritizing high-risk practices and exploring new emerging ones associated with hepatitis C virus infection in Egypt. Iran. J. Public. Health. 43 (10), 1385\u20131394 (2014). PMID: 26060701; PMCID: PMC4441892.","journal-title":"Iran. J. Public. Health"},{"key":"37013_CR75","doi-asserted-by":"publisher","unstructured":"Metwally, A. M. et al. Level of behavioral development for hepatitis C virus cases versus their contacts: does infection make a difference and what is beyond? Int. J. Med. Sci. Eng. 7 (12). https:\/\/doi.org\/10.5281\/zenodo.1089507 (2013).","DOI":"10.5281\/zenodo.1089507"},{"key":"37013_CR76","doi-asserted-by":"publisher","unstructured":"Shiha, G. et al. An educate, test, and treat programme to reduce hepatitis C in Egypt: results from a community-based demonstration project. Lancet Gastroenterol Hepatol. ;3(11):778\u201389. (2018). https:\/\/doi.org\/10.1016\/S2468-1253(18)30139-0. PMID: 30030068.","DOI":"10.1016\/S2468-1253(18)30139-0"},{"issue":"14","key":"37013_CR77","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.vaccine.2018.02.103","volume":"36","author":"II Salama","year":"2018","unstructured":"Salama, I. I. et al. Early and long-term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy. Vaccine 36 (14), 2005\u20132011. https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.103 (2018).","journal-title":"Vaccine"},{"issue":"7","key":"37013_CR78","doi-asserted-by":"publisher","first-page":"e0235715","DOI":"10.1371\/journal.pone.0235715","volume":"15","author":"A Palayew","year":"2020","unstructured":"Palayew, A. et al. The Hep-CORE policy score: a European hepatitis C National policy implementation ranking based on patient organization data. PLoS One. 15 (7), e0235715. https:\/\/doi.org\/10.1371\/journal.pone.0235715 (2020).","journal-title":"PLoS One"},{"issue":"17","key":"37013_CR79","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.3889\/oamjms.2019.624","volume":"7","author":"AM Metwally","year":"2019","unstructured":"Metwally, A. M. et al. Effect of counteracting lifestyle barriers through health education in Egyptian type 2 diabetic patients. Open. Access. Maced J. Med. Sci. 7 (17), 2886\u20132894. https:\/\/doi.org\/10.3889\/oamjms.2019.624 (2019).","journal-title":"Open. Access. Maced J. Med. Sci."},{"issue":"1","key":"37013_CR80","doi-asserted-by":"publisher","first-page":"4","DOI":"10.26719\/2013.19.1.4","volume":"19","author":"AMA Ahmed","year":"2013","unstructured":"Ahmed, A. M. A. et al. Compliance with haemodialysis practice guidelines in Egypt. East. Mediterr. Health J. 19 (1), 4\u20139. https:\/\/doi.org\/10.26719\/2013.19.1.4 (2013).","journal-title":"East. Mediterr. Health J."},{"issue":"1","key":"37013_CR81","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12939-019-1042-y","volume":"18","author":"AM Metwally","year":"2019","unstructured":"Metwally, A. M. et al. Enhancing the value of women\u2019s reproductive rights through community-based interventions in upper Egypt governorates: a randomized interventional study. Int. J. Equity Health. 18 (1), 146. https:\/\/doi.org\/10.1186\/s12939-019-1042-y (2019).","journal-title":"Int. J. Equity Health"},{"key":"37013_CR82","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s12913-020-05412-1","volume":"20","author":"AM Metwally","year":"2020","unstructured":"Metwally, A. M. et al. Strengths of community- and health facility-based interventions in improving women and adolescents\u2019 care-seeking behaviors: approaches for reducing maternal mortality and improving birth outcomes among low-income communities in Egypt. BMC Health Serv. Res. 20, 592. https:\/\/doi.org\/10.1186\/s12913-020-05412-1 (2020).","journal-title":"BMC Health Serv. Res."},{"key":"37013_CR83","doi-asserted-by":"crossref","unstructured":"Metwally, A. M. et al. Impact of nutritional health education on knowledge and practices of mothers of anemic children in El Othmanyia village \u2013 Egypt. Open Access Maced J Med Sci. 8(E):458\u201365. (2020). Available from: https:\/\/www.id-press.eu\/mjms\/article\/view\/4570","DOI":"10.3889\/oamjms.2020.4570"},{"key":"37013_CR84","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS, 2016)."},{"issue":"6","key":"37013_CR85","doi-asserted-by":"publisher","first-page":"e0252996","DOI":"10.1371\/journal.pone.0252996","volume":"16","author":"AM Metwally","year":"2021","unstructured":"Metwally, A. M. et al. Egyptian patients\u2019\/guardians\u2019 experiences and perception about clinical informed consent and its purpose: cross-sectional study. PLoS One. 16 (6), e0252996. https:\/\/doi.org\/10.1371\/journal.pone.0252996 (2021).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37013-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37013-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37013-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:30:41Z","timestamp":1781634641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37013-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37013"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37013-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ain Shams Faculty of Medicine Ethics Committee and the Medical Research Ethics Committee of the National Research Centre withan ethical approval number 10120 obtained on 03\/08\/2021. Written informed consent was obtained from all participating adult men prior to interview. Participation was entirely voluntary, and all data were collected confidentially. Personal identifiers were removed, and records were securely stored. The study adhered to the International Ethical Guidelines for Biomedical Research Involving Human Subjects\n                      84\n                      . Adequate information disclosure was ensured, in line with recommendations emphasizing the importance of informed consent among Egyptian patients and guardians\n                      85\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical consideration"}}],"article-number":"7381"}}